Derma has two products in development. The NIMBUS technology based line of barrier gauze and DSC127 the company novel angiotensin analog for accelerated wound healing and scar reduction The barrier technology was developed by Quick – Med on the 1st Quarter of licensed licensed to its first marketing approval marketing approval. Generalists approved by the University of Southern California in Q4 of 2007 and will start in a phase II study entry, with expected initial patient enrollment in Q3 2008. For more information about Derma Sciences, please visit the Internet website at.. About Derma SciencesDerma Sciences is a global manufacturer and marketer of advanced wound care products.

– Hospital costs associated with deliveries of women with preexisting diabetes were 55 % higher and for women with gestational diabetes they 18 % by 18 % than in women who do not have diabetes 3rd (.– Severity reduces Having omega -3 fatty acidsA diet rich in omega 3 fatty acids reduced the severity of brain damage a stroke, after a study made of Universit? Laval scientists. The team at teachers Jasna Kriz and Friday? AIC Calon co-director, that the level of brain damages after stroke by 25 percent for mice consumes DHA type omega -3 fatty acids daily been reduced. Details study can found on the web site the journal Stroke.